IO Biotech Inc (IOBT): Next-Year EPS Estimate 59.09%
As of 2026-04-16, IO Biotech Inc (IOBT) has a next-year EPS growth estimate of 59.09%.
On 2026-04-12, analyst consensus for IOBT's next-year EPS growth shifted from 66.67% to 59.09% — a negative change of 7.58 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 34.83%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 59.09%
- EPS growth this year
- 34.83%
- EPS next quarter (est)
- -$0.14
- Last price
- $0.05
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-16 | 59.09% | 34.83% | -$0.14 | $0.05 |
| 2026-04-15 | 59.09% | 34.83% | -$0.14 | $0.05 |
| 2026-04-14 | 59.09% | 34.83% | -$0.14 | $0.05 |
| 2026-04-13 | 59.09% | 34.83% | -$0.14 | $0.05 |
| 2026-04-12 | 59.09% | 34.83% | -$0.14 | $0.05 |
| 2026-04-10 | 66.67% | 59.09% | N/A | $0.05 |
| 2026-04-09 | 66.67% | 59.09% | N/A | $0.05 |
| 2026-04-08 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-07 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-06 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-05 | 66.67% | N/A | N/A | $0.03 |
| 2026-04-03 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-02 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-01 | 66.67% | N/A | N/A | $0.05 |
| 2026-04-01 | 66.67% | N/A | N/A | $0.06 |
| 2026-04-01 | 66.67% | N/A | N/A | $0.04 |
| 2026-04-01 | 66.67% | N/A | N/A | $0.04 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is IO Biotech Inc's next-year EPS growth estimate?▾
As of 2026-04-16, IO Biotech Inc (IOBT) has a next-year EPS growth estimate of 59.09%, based on analyst consensus.
When was the latest EPS estimate revision for IOBT?▾
The most recent revision occurred on 2026-04-12, when analysts adjusted the next-year EPS growth estimate from 66.67% to 59.09%.
What sector and industry does IO Biotech Inc belong to?▾
IO Biotech Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IOBT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. IO Biotech Inc (IOBT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports